Home

search

Subjectguide
Journals
Books / Serials / Multimedia
Services
Services

Login for Subscribers
Logout

Sitemap
Help
Contacts


Logo






Vol. 65, No. 3, 2008   

Free Abstract     Article (References)     Article (PDF 553 KB)     

Original Paper

Prioritized Subset Analysis: Improving Power in Genome-wide Association Studies
Chun Lia, b, Mingyao Lic, Ethan M. Langed, e, Richard M. Watanabef, g

aDepartment of Biostatistics,
bCenter for Human Genetics Research, Vanderbilt University School of Medicine, Nashville, Tenn.,
cDepartment of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pa., Departments of
dGenetics and
eBiostatistics, University of North Carolina, Chapel Hill, N.C., Departments of
fPreventive Medicine and
gPhysiology & Biophysics, Keck School of Medicine of USC, Los Angeles, Calif., USA

Address of Corresponding Author

Hum Hered 2008;65:129-141 (DOI: 10.1159/000109730)


 goto top of page Key Words

  • Association analysis
  • False discovery rate
  • HapMap

 goto top of page Abstract

Background: Genome-wide association studies (GWAS) are now feasible for studying the genetics underlying complex diseases. For many diseases, a list of candidate genes or regions exists and incorporation of such information into data analyses can potentially improve the power to detect disease variants. Traditional approaches for assessing the overall statistical significance of GWAS results ignore such information by inherently treating all markers equally. Methods: We propose the prioritized subset analysis (PSA), in which a prioritized subset of markers is pre-selected from candidate regions, and the false discovery rate (FDR) procedure is carried out in the prioritized subset and its complementary subset, respectively. Results: The PSA is more powerful than the whole-genome single-step FDR adjustment for a range of alternative models. The degree of power improvement depends on the fraction of associated SNPs in the prioritized subset and their nominal power, with higher fraction of associated SNPs and higher nominal power leading to more power improvement. The power improvement can be substantial; for disease loci not included in the prioritized subset, the power loss is almost negligible. Conclusion: The PSA has the flexibility of allowing investigators to combine prior information from a variety of sources, and will be a useful tool for GWAS.

Copyright © 2007 S. Karger AG, Basel


 goto top of page Author Contacts

Chun Li
Center for Human Genetics Research
Vanderbilt University School of Medicine, 519 Light Hall
Nashville, TN 37232 (USA)
Tel. +1 615 322 2884, Fax +1 615 343 8619, E-Mail chun.li@vanderbilt.edu


 goto top of page Article Information

C. Li and M. Li made equal contributions.

Received: March 22, 2007
Accepted after revsion: June 14, 2007
Published online: October 12, 2007
Number of Print Pages : 13
Number of Figures : 6, Number of Tables : 0, Number of References : 17

 
Journal Home
Journal Content
Guidelines
Editorial Board
Aims and Scope
Subscriptions
Medline Abstract (ID 17934316)
Download Citation
Cited In



Special offer for members of genetics societies

This journal is part of the second subject package of the Karger

Journal Archive Collection

Information on packages (PDF)
Free sample issues


For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service.





copyright  © 2009 S. Karger AG, Basel